RDGL — VIVOS INC
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1449349 ·
Last close
$0.04
Market Cap
$21.07M
52W High
$0.12
52W Low
$0.04
ADV30
608,589
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2026 | 28,900 | 21,462 | -748,838 | -731,594 | 2,284,340 | 1,807,350 | 221,600 |
| Jun 2026 | 36,400 | -1,720 | -654,529 | -830,189 | 2,879,570 | 2,336,022 | 123,955 |
| Mar 2026 | 36,068 | -8,018 | -545,492 | -1,184,845 | 2,950,505 | 2,525,782 | 253,195 |
| Dec 2025 | 24,752 | -3,105 | -1,095,719 | -1,078,514 | 1,867,583 | 1,558,525 | 206,743 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-2,167,476
Investing CF
$-245,744
Financing CF
$2,191,837
CapEx
$-245,744
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.00
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-90,442,280
Inventory
$56,427
Receivables
$15,650
ST Investments
—
EBIT TTM
$-2,806,423
Pretax Income TTM
$-3,600,842
Interest Exp TTM
$196,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$99,099
EBITDA
—
Free Cash Flow
$-1,544,673
Enterprise Value
$31,625,180
Total Cash
$2,336,022
Total Debt
$103,153
Shares Out
513,788,110
Trailing EPS
$-0.01
Book Value
$-0.02
ROE
-132.5%
ROA
-62.5%
Div Yield
0.00%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 68,379 | -3,165,047 | -3,066,017 | 1,867,583 | 206,743 | 1,660,840 | -2,057,743 |
| Dec 2024 | 27,995 | -2,604,384 | -2,910,448 | 2,233,456 | 86,209 | 2,147,247 | -1,684,039 |
| Dec 2023 | 19,500 | -2,793,146 | -2,894,753 | 1,610,124 | 245,004 | 1,365,120 | -1,293,023 |
| Dec 2022 | 36,499 | -2,517,749 | -2,470,161 | 1,742,736 | 81,692 | 1,661,044 | -1,120,058 |
TTM Snapshot
Revenues TTM
$99,099
NetIncome TTM
$-3,600,842
OpCashFlow TTM
—
Assets (Latest)
$2,879,570
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BEAT | HeartBeam, Inc. | $21.13M | $0.33 | — |
| NNOX | Nano-X Imaging Ltd. | $22.59M | $0.29 | — |
| ITOC | iTonic Holdings Ltd | $18.39M | $1.96 | — |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | $24.66M | $0.80 | — |
| QTI | QT IMAGING HOLDINGS, INC. | $24.83M | $1.69 | — |
News headlines (Yahoo Finance, 1h cache)
How Is Vivos Expanding Its IsoPet Cancer Treatment Network With Four New US Veterinary Clinics?
2026-11-03 16:16 · Yahoo
Vivos Inc. Announces Expansion of IsoPet® Animal Cancer Division with Four New Veterinary Clinics Across the United States
2026-11-03 13:30 · Yahoo
CORRECTION: SOD Sciences Welcomes Vivos Therapeutics as Strategic Investor and Partner in the ReBalU Primed Cell Test
2026-10-29 14:52 · Yahoo
SOD Sciences Welcomes Vivos Therapeutics as Strategic Investor and Partner in the ReBalU Primed Cell Test
2026-10-20 15:40 · Yahoo
Vivos Therapeutics Closes Acquisition of Stake in SOD Sciences and 50% Interest in Pseudohypoxia Test, Opening a Potential Path to Access More Than 325,000 New Patients Through the AHA Channel
2026-10-19 21:01 · Yahoo
Vivos Inc. Peer-Reviewed PrecisionGel Publication Strengthens Scientific Case for Drug Delivery Platform
2026-09-03 13:59 · Yahoo
Vivos Therapeutics and South Palm Cardiovascular Associates Sign Definitive Agreements to Launch Regional Sleep Testing and Treatment Center
2026-08-28 12:45 · Yahoo
Vivos Begins IsoPet Shipments and Secures India Manufacturing Authorization
2026-08-18 14:47 · Yahoo
Vivos Inc. Achieves Two Major Operational Milestones: First IsoPet® Shipments from New U.S. Production Facility and Authorization from India’s Nuclear Regulatory Authority for International Manufactur
2026-08-18 12:30 · Yahoo
Vivos Therapeutics Schedules Release of Second Quarter 2026 Financial Results and Conference Call
2026-08-14 12:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.